Page last updated: 2024-10-16

carbamates and Cholesterol Ester Storage Disease

carbamates has been researched along with Cholesterol Ester Storage Disease in 2 studies

Cholesterol Ester Storage Disease: An autosomal recessive disorder caused by mutations in the gene for acid lipase (STEROL ESTERASE). It is characterized by the accumulation of neutral lipids, particularly CHOLESTEROL ESTERS in leukocytes, fibroblasts, and hepatocytes.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dairaku, T1
Iwamoto, T1
Nishimura, M1
Endo, M1
Ohashi, T1
Eto, Y1
Civallero, G1
De Mari, J1
Bittar, C1
Burin, M1
Giugliani, R1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Frequency of Cholesteryl Ester Storage Disease in Children With Unexplained Transaminase Elevation and Chronic Liver Disease[NCT02372513]810 participants (Actual)Observational2015-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for carbamates and Cholesterol Ester Storage Disease

ArticleYear
A practical fluorometric assay method to measure lysosomal acid lipase activity in dried blood spots for the screening of cholesteryl ester storage disease and Wolman disease.
    Molecular genetics and metabolism, 2014, Volume: 111, Issue:2

    Topics: Adult; Biomarkers; Carbamates; Case-Control Studies; Cholesterol Ester Storage Disease; Dried Blood

2014
Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease.
    Gene, 2014, Apr-10, Volume: 539, Issue:1

    Topics: Carbamates; Cells, Cultured; Cholesterol Ester Storage Disease; Dried Blood Spot Testing; Fibroblast

2014